147 related articles for article (PubMed ID: 36899018)
1. Inhibition of CDKL3 downregulates STAT1 thus suppressing prostate cancer development.
Jiang Q; Li J; Wang J; Zhang W
Cell Death Dis; 2023 Mar; 14(3):189. PubMed ID: 36899018
[TBL] [Abstract][Full Text] [Related]
2. Identification of CDKL3 as a critical regulator in development of glioma through regulating RRM2 and the JNK signaling pathway.
Cui Y; Yang Z; Wang H; Yan Y; Huang Q; Gong Z; Hong F; Zhang X; Li W; Chen J; Xu T
Cancer Sci; 2021 Aug; 112(8):3150-3162. PubMed ID: 34097336
[TBL] [Abstract][Full Text] [Related]
3. Cyclin-dependent kinase like 3 promotes triple-negative breast cancer progression via inhibiting the p53 signaling pathway.
Zeng DX; Sheng GF; Liu YP; Zhang YP; Qian Z; Li Z; Bi YZ
Neoplasma; 2021 Sep; 68(5):1033-1042. PubMed ID: 34427098
[TBL] [Abstract][Full Text] [Related]
4. CDKL3 promotes osteosarcoma progression by activating Akt/PKB.
He A; Ma L; Huang Y; Zhang H; Duan W; Li Z; Fei T; Yuan J; Wu H; Liu L; Bai Y; Dai W; Wang Y; Li H; Sun Y; Wang Y; Wang C; Yuan T; Yang Q; Tian S; Dong M; Sheng R; Xiang D
Life Sci Alliance; 2020 May; 3(5):. PubMed ID: 32234750
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow mesenchymal stem cells-secreted exosomal microRNA-205-5p exerts inhibitory effect on the progression of liver cancer through regulating CDKL3.
Sun Q; Zhang X; Tan Z; Gu H; Ding S; Ji Y
Pathol Res Pract; 2021 Sep; 225():153549. PubMed ID: 34329837
[TBL] [Abstract][Full Text] [Related]
6. CDKL3 Targets ATG5 to Promote Carcinogenesis of Esophageal Squamous Cell Carcinoma.
Zhou S; Zhang M; Zhou C; Wang W; Yang H; Ye W
Front Oncol; 2020; 10():1602. PubMed ID: 32974198
[TBL] [Abstract][Full Text] [Related]
7. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
[TBL] [Abstract][Full Text] [Related]
8. ERK expression and its correlation with STAT1 in esophageal squamous cell carcinoma.
Wang H; Zhang Y; Yun H; Chen S; Chen Y; Liu Z
Oncotarget; 2017 Jul; 8(28):45249-45258. PubMed ID: 28431406
[TBL] [Abstract][Full Text] [Related]
9. Increased CDKL3 expression predicts poor prognosis and enhances malignant phenotypes in esophageal squamous cell carcinoma.
Ye W; Zhu J; He D; Yu D; Yang H; Wang W; Zhang M; Zhou S
J Cell Biochem; 2019 May; 120(5):7174-7184. PubMed ID: 30387188
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of cell proliferation in various mammalian cell lines by gene insertion of a cyclin-dependent kinase homolog.
Jaluria P; Betenbaugh M; Konstantopoulos K; Shiloach J
BMC Biotechnol; 2007 Oct; 7():71. PubMed ID: 17945021
[TBL] [Abstract][Full Text] [Related]
11. Curcumol Exerts Anticancer Effect in Cholangiocarcinoma Cells via Down-Regulating CDKL3.
Zhang J; Su G; Tang Z; Wang L; Fu W; Zhao S; Ba Y; Bai B; Yue P; Lin Y; Bai Z; Hu J; Meng W; Qiao L; Li X; Xie X
Front Physiol; 2018; 9():234. PubMed ID: 29615928
[TBL] [Abstract][Full Text] [Related]
12. Enhanced redundancy in Akt and mitogen-activated protein kinase-induced survival of malignant versus normal prostate epithelial cells.
Uzgare AR; Isaacs JT
Cancer Res; 2004 Sep; 64(17):6190-9. PubMed ID: 15342404
[TBL] [Abstract][Full Text] [Related]
13. Lemur Tyrosine Kinase-3 Suppresses Growth of Prostate Cancer Via the AKT and MAPK Signaling Pathways.
Sun P; Sun X; Zhao W; Ren M; Zhang C; Wang Z; Xu W
Cell Physiol Biochem; 2017; 42(6):2582-2592. PubMed ID: 28848113
[TBL] [Abstract][Full Text] [Related]
14. miR-2909 regulates ISGylation system via STAT1 signalling through negative regulation of SOCS3 in prostate cancer.
Ayub SG; Kaul D
Andrology; 2017 Jul; 5(4):790-797. PubMed ID: 28622443
[TBL] [Abstract][Full Text] [Related]
15. Loss of signal transducer and activator of transcription 1 is associated with prostate cancer recurrence.
Hatziieremia S; Mohammed Z; McCall P; Willder JM; Roseweir AK; Underwood MA; Edwards J
Mol Carcinog; 2016 Nov; 55(11):1667-1677. PubMed ID: 26495772
[TBL] [Abstract][Full Text] [Related]
16. MiRNA203 suppresses the expression of protumorigenic STAT1 in glioblastoma to inhibit tumorigenesis.
Yang CH; Wang Y; Sims M; Cai C; He P; Yue J; Cheng J; Boop FA; Pfeffer SR; Pfeffer LM
Oncotarget; 2016 Dec; 7(51):84017-84029. PubMed ID: 27705947
[TBL] [Abstract][Full Text] [Related]
17. S100A16 promotes cell proliferation and metastasis via AKT and ERK cell signaling pathways in human prostate cancer.
Zhu W; Xue Y; Liang C; Zhang R; Zhang Z; Li H; Su D; Liang X; Zhang Y; Huang Q; Liu M; Li L; Li D; Zhao AZ; Liu Y
Tumour Biol; 2016 Sep; 37(9):12241-12250. PubMed ID: 27240591
[TBL] [Abstract][Full Text] [Related]
18. Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis.
Aranha O; Grignon R; Fernandes N; McDonnell TJ; Wood DP; Sarkar FH
Int J Oncol; 2003 Apr; 22(4):787-94. PubMed ID: 12632069
[TBL] [Abstract][Full Text] [Related]
19. Inactivition of CDKL3 mildly inhibits proliferation of cells at VZ/SVZ in brain.
Liu Z; Tao D
Neurol Sci; 2015 Feb; 36(2):297-302. PubMed ID: 25270654
[TBL] [Abstract][Full Text] [Related]
20. ERK is a negative feedback regulator for IFN-γ/STAT1 signaling by promoting STAT1 ubiquitination.
Zhang Y; Chen Y; Liu Z; Lai R
BMC Cancer; 2018 May; 18(1):613. PubMed ID: 29855346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
